Foreword

Research & Development

Nanotechnology Promise

Partnerships

A pill for growth

Caught in the “Innovation Deficiency Syndrome”, and under serious pressure to compensate declining revenue streams from saturated markets, soon-to-expire / already expired blockbusters, pharma companies are increasingly partnering with biotechs to help reduce their losses.

Drug Discovery

Back to Mother Nature

Natural products-based drug discovery is gaining prominence once again.

Kittens to Tigers

Globalisation, free trade, investment, entrepreneurial zeal are all set to metamorphose Indian pharma companies that were once labelled as the copy cat drug makers into discovery-led firms.

Asia's Two

Fold Opportunity

The Asian pharmaceutical industry presents a two-fold opportunity to the troubled world of the global pharma industry.

Asia Goes Global

Welcome to the latest edition of Pharma Focus Asia. The issue of outsourcing in the pharmaceutical sector has been a hot topic for discussion recently, particularly now that the US Congress is considering reforming patent law. The new legislation could have significant repercussions for firms that use the USA as part of their business strategy, especially as pharmaceutical and biotechnology companies now outsource at almost every stage in the value chain.